TScan Therapeutics Inc <TCRX.O>: Needham cuts to hold from buy
TCRX•Related News
Diversified Energy forecasts 2026 adjusted EBITDA of $985 million, free cash flow of $440 million
DEC•
Encore Energy Corp. <EU.O>: Jefferies initiates coverage with buy rating; target price $1.44
EU•
Oil edges down as investors weigh uncertainty over U.S.-Iran strikes
XLE•
Nasdaq trade halt <APGE.O> trading halted; for information requested by Nasdaq at 07:50 PM
APGE•
Ultragenyx Pharmaceutical Inc. <RARE.O>: JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $36 From $80
RARE•